NCT02484664
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
Clinical trial condition
Lymphangioleiomyomatosis
Explore clinical trials studying Lymphangioleiomyomatosis. Study availability and eligibility vary by location and protocol.
41 public trials
10 recruiting studies
Lymphangioleiomyomatosis trial results
NCT03525834
- Conditions
- Angiomyolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +26 more
- Locations
-
- Novartis Investigative Site Wuhan, Hubei, China
- Novartis Investigative Site Shanghai, Shanghai Municipality, China
- Novartis Investigative Site Chengdu, Sichuan, China
- Novartis Investigative Site Beijing, China
Completed
Glutamine PET Imaging in LAM
NCT04388371
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Vanderbilt University Medical Center Nashville, Tennessee, United States
NCT00366509
- Conditions
- Asthma, Bronchial Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +28 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01059318
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Center for LAM Research and Clinical Care Boston, Massachusetts, United States
- University of Cincinnati, Department of Internal Medicine, Pulmonary, Critical Care & Sleep Medicine, Cincinnati, Ohio, United States
- Novartis Investigative Site Lyon, France
- Novartis Investigative Site Milan, Italy
Completed
Safety of Simvastatin in LAM and TSC
NCT02061397
- Conditions
- Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +24 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
Completed
LAM Pilot Study With Imatinib Mesylate
NCT03131999
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Columbia University New York, United States
- Medical University of South Carolina Charleston, South Carolina, United States
Completed
Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM)
NCT04184193
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- Schoen Klinik Berchtesgadener Land Schönau am Königssee, Germany
NCT00552955
- Conditions
- Ascites, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +27 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01687179
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States